An unusual case of primary hyperparathyroidism with profoundly elevated parathyroid hormone levels

Endocrine Practice

Volumn 14, Issue 7, 2008, Pages 892-897

  Moore, Allan F ^a   Wexler, Tamara L ^a   Yung, Rachel L ^b   Kish, Joshua ^a   Larvie, Mykol ^a   Lauter, Kelly ^c   Arnold, Andrew ^c   Finkelstein, Joel S ^a   Burnett Bowie, Sherri Ann M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CALCITRIOL; CALCIUM CARBONATE; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; FUROSEMIDE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PARATHYROID HORMONE; VINCRISTINE; CDC73 PROTEIN, HUMAN; DIAGNOSTIC AGENT; TUMOR SUPPRESSOR PROTEIN;

ABDOMINAL NEUROBLASTOMA; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CDC73 GENE; CHILDHOOD CANCER; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; GENETIC ANALYSIS; GENETICS; HISTOPATHOLOGY; HORMONE DETERMINATION; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; KIDNEY DISEASE; MALE; METABOLIC BONE DISEASE; NEUROBLASTOMA; PAIN; PARATHYROID CARCINOMA; PARATHYROID HORMONE BLOOD LEVEL; PHYSICAL EXAMINATION; PRIMARY HYPERPARATHYROIDISM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SWELLING; THORAX; THYROID MASS; TUMOR GENE; METABOLISM; PARATHYROID TUMOR; PATHOLOGY;

ADULT; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; PARATHYROID HORMONE; PARATHYROID NEOPLASMS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TUMOR SUPPRESSOR PROTEINS;

EID: 64749111610     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.14.7.892     Document Type: Article

References (23)

1. Shattuck TM, Välimäki S, Obara T, et al. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med. 2003;349:1722-1729.
2. Rodgers SE, Lew JI, Solórzano CC. Primary hyperparathyroidism. Curr Opin Oncol. 2008;20:52-58.
3. Ruda JM, Hollenbeak CS, Stack BC Jr. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg. 2005;132:359-372.
4. Wermers RA, Khosla S, Atkinson EJ, et al. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: An update on the changing epidemiology of the disease. J Bone Miner Res. 2006;21:171-177.
5. Sitges-Serra A, Bergenfelz A. Clinical update: Sporadic primary hyperparathyroidism. Lancet. 2007;370:468-470.
6. Silverberg SJ, Bilezikian JP. The diagnosis and management of asymptomatic primary hyperparathyroidism. Nat Clin Pract Endocrinol Metab. 2006;2:494-503.
7. Rodgers SE, Perrier ND. Parathyroid carcinoma. Curr Opin Oncol. 2006;18:16-22.
8. Holmes EC, Morton DL, Ketcham AS. Parathyroid carcinoma: A collective review. Ann Surg. 1969;169:631-640.
9. Shane E, Bilezikian JP. Parathyroid carcinoma: A review of 62 patients. Endocr Rev. 1982;3:218-226.
10. Shane E. Clinical review 122: Parathyroid carcinoma. J Clin Endocrinol Metab. 2001;86:485-493.
11. Obara T, Fujimoto Y. Diagnosis and treatment of patients with parathyroid carcinoma: An update and review. World J Surg. 1991;15:738-744.
12. Wynne AG, van Heerden J, Carney JA, Fitzpatrick LA. Parathyroid carcinoma: Clinical and pathologic features in 43 patients. Medicine (Baltimore). 1992;71:197-205.
13. Schantz A, Castleman B. Parathyroid carcinoma. A study of 70 cases. Cancer. 1973;31:600-605.
14. Hsi ED, Zukerberg LR, Yang WI, Arnold A. Cyclin D1/ PRAD1 expression in parathyroid adenomas: An immunohistochemical study. J Clin Endocrinol Metab. 1996;81: 1736-1739.
15. Arnold A, Shattuck TM, Mallya SM, et al. Molecular pathogenesis of primary hyperparathyroidism. J Bone Miner Res. 2002;17(Suppl 2):30-36.
16. Cetani F, Pardi E, Borsari S, et al. Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: Germline and somatic mutations in familial and sporadic parathyroid tumors. J Clin Endocrinol Metab. 2004;89:5583-5591.
17. Cetani F, Ambrogini E, Viacava P, et al. Should parafibromin staining replace HRPT2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinomas? Eur J Endocrinol. 2007;156:547-554.
18. Agarwal G, Dhingra S, Mishra SK, Krishnani N. Implantation of parathyroid carcinoma along fine needle aspiration track. Langenbecks Arch Surg. 2006;391:623-626.
19. Kebebew E. Parathyroid carcinoma. Curr Treat Options Oncol. 2001;2:347-354.
20. NIH Conference. Diagnosis and management of asymptomatic primary hyperparathyroidism: Consensus development conference statement. Ann Intern Med. 1991;114:593-597.
21. Bilezikian JP, Potts JT Jr, Fuleihan Gel-H, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: A perspective for the 21st century. J Clin Endocrinol Metab. 2002;87:5353-5361.
22. Silverberg SJ, Rubin MR, Faiman C, et al. Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma. J Clin Endocrinol Metab. 2007;92:3803-3808.
23. Mittendorf EA, McHenry CR. Parathyroid carcinoma. J Surg Oncol. 2005;89:136-142.